IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $587,000 | -4.6% | 46,400 | 0.0% | 0.14% | -9.2% |
| Q4 2016 | $615,000 | -78.0% | 46,400 | -22.1% | 0.15% | -71.2% |
| Q1 2015 | $2,792,000 | +22.9% | 59,563 | -16.9% | 0.53% | +21.2% |
| Q4 2014 | $2,271,000 | +113.0% | 71,683 | +59.4% | 0.44% | +265.8% |
| Q3 2014 | $1,066,000 | -25.5% | 44,971 | -5.7% | 0.12% | -23.1% |
| Q2 2014 | $1,430,000 | +13.5% | 47,700 | 0.0% | 0.16% | +8.3% |
| Q1 2014 | $1,260,000 | +72.4% | 47,700 | +63.9% | 0.14% | +63.6% |
| Q4 2013 | $731,000 | – | 29,100 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |